The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,676,724 in first-year total cost, median $1,329,765.
Most frequent study sections
- Special Emphasis Panel[ZAI1 LR-M (M1)]5
Most frequent institutions
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- BRIGHAM AND WOMEN'S HOSPITAL1
- GUILD ASSOCIATES, INC.1
- JOHNS HOPKINS UNIVERSITY1
- TALIS BIOMEDICAL CORPORATION1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Rapid, Breath Volatile Metabolite-Based Diagnostic for In Vivo Identification and Antibiotic Resistance Profiling of Bacterial Pathogens in Ventilator-Associated Pneumonia1R01AI138999-01 | KOO, SOPHIA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,495,043 | ZAI1 |
| 2018 | Technology development for point-of-care detection and antimicrobial susceptibility testing of Neisseria gonorrhoeae1R01AI138978-01 | GAYDOS, CHARLOTTE ANNWANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY, MD | $1,369,638 | ZAI1 |
| 2018 | Point-of-care antimicrobial susceptibility testing based on simultaneous tracking of multi-phenotypic features of single bacterial cells1R01AI138993-01 | TAO, NONGJIAN | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $1,329,765 | ZAI1 |
| 2018 | Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.1R01AI139005-01 | GOLDBERG, MARTINMAAMAR, HEDIA | TALIS BIOMEDICAL CORPORATION, IL | $1,251,580 | ZAI1 |
| 2018 | Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens1R01AI138971-01 | SCHOFIELD, DAVID A | GUILD ASSOCIATES, INC., OH | $1,230,698 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.